Research paper
Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity

https://doi.org/10.1016/j.ejmech.2020.112202Get rights and content

Highlights

  • Oligopyrrole carboxamides conjugated anthraquinone derivatives stabilize G-quadruplex DNA over duplex DNA.

  • Oligopyrrole carboxamides conjugated anthraquinone derivatives stabilize promoter G-quadruplex DNA.

  • Stacking mode of interaction of the ligand with c-MYC G-quadruplex DNA.

  • Selective cancer cell cytotoxicity over normal cells was obtained upon treatment of these ligands.

  • Cellular morphological changes and nuclear condensation observed in the ligand treated cells.

Abstract

We have designed and synthesized anthraquinone containing compounds which have oligopyrrole side chains of varying lengths. These compounds stabilized the G-quadruplex DNA formed in the promoter regions of c-MYC oncogenes selectively over the duplex DNA. These observations were recorded using UV–vis spectroscopic titrations, fluorescence measurements and circular dichroism (CD) spectral titrations. The potency of the compounds to stabilize the G4 DNA has been shown from the thermal denaturation experiments. The compound interacts with c-MYC G-quadruplex DNA through stacking mode as obtained from ethidium bromide displacement assay, cyclic voltammetric titration, and docking experiments. Molecular modeling studies suggested that the stacking of the anthraquinone moiety over the G-tetrad of the G4 structures are responsible for the stability of such quadruplex secondary structure. Furthermore, polymerase stop assay also supported the formation of stable G4 structures in the presence of the above-mentioned compounds. The compounds have shown selective cancer cell (HeLa and HEK293T) cytotoxicity over normal cells (NIH3T3 and HDFa) under in vitro conditions as determined from MTT based cell viability assay. Apoptosis was found to be the mechanistic pathway underlying the cancer cell cytotoxicity as obtained from Annexin V-FITC and PI dual staining assay which was further substantiated by nuclear morphological changes as observed by AO/EB dual staining assay. Cellular morphological changes, as well as nuclear condensation and fragmentation upon treatment with these compounds, were observed under bright field and confocal microscopy.

Introduction

Guanine-rich short deoxyribonucleic acid sequences can fold into G-quadruplex (G4) DNA structures arising out of various non-covalent supramolecular interactions such as Hoogsteen type hydrogen bonds (between N1–O6 and N2–N7) and π–π stacking interactions among the heteroatomic nucleobases [1]. The central cavities of the four-stranded G4 assembly are further stabilized by monovalent cations such as Na+ and K+ which coordinate with the O6 lone pair of each guanine moiety, which in turn reduces the charge repulsion [2]. G-quadruplex DNA structures adopt various topologies such as parallel, anti-parallel, mixed hybrid etc. depending upon the length of the G-rich sequences, size/length of the loop, the conformation of the glycosidic bonds, and the presence of the centrally coordinated metal ions [1,3]. Intermediate sequences between the G-tetrad forming guanines form loops which play a significant role in regulating the nature of folding and stability of the G-quadruplex [4]. Further, depending upon the number of participating strands in the quadruplex DNA structure, G-quadruplexes can be classified into three groups such as tetramolecular, bimolecular, and monomolecular, or intramolecular [5]. Such G-quadruplex DNA structures have indeed been detected and visualized at the cellular level by employing a highly structure-specific antibody [6].

Various cellular processes like transcription, translation, the activity of telomerase enzyme may be regulated by stabilizing the G-quadruplex DNA structures that have been recognized in the human genome such as in the promoter region of some oncogenes as well as in the telomeric 3′-overhangs that comprise a tandem repeat of the d(TTAGGG)n units [7]. The promoter regions of many proto-oncogenes like c-MYC, c-KIT, BCL-2, k-RAS, VEGF, HIF-1α contain G-rich sequences that have a high tendency of forming G4 structures [8]. Thus, small molecules, which can stabilize these G-quadruplex DNA structures, may also downregulate the protein expressions and inhibit the cellular functions that can eventually lead to cell death [9]. In a general strategy, small molecules which have large π-surface(s) are designed to interact with the G-tetrad through π-π interactions and neutral/cationic side chains are incorporated to favorably interact with the phosphate backbone of the groove/loop to get adequate quadruplex binding selectivity over duplex DNA [10].

Anthraquinone-based compounds have shown effective DNA binding properties and can act as anti-cancer agents [11]. Anthraquinone is the structural element of anthracyclines like doxorubicin and daunomycin which have been introduced in clinical uses for the treatment of various types of cancers and are well-known DNA binders [12]. Besides these, anthraquinone derivatives have various pharmacological applications like anti-inflammatory, antiarthritic, antifungal, antibacterial and moreover, they have shown potential activity in malaria treatment and multiple sclerosis [13].

In the last few decades, many chemical compounds have been synthesized and studied for the selective stabilization of G-quadruplex DNA [14]. A major challenge for designing G-quadruplex mediated anti-cancer agents is to improve the selectivity for binding towards G-quadruplex over duplex DNA [15]. Small molecules containing acridine, furan, salen, anthraquinone, carbazole, benzimidazole, salphen, xanthone pharmacophore have been extensively studied for the stabilization of G-quadruplex DNA [16]. Anthraquinones were one of the first reported ligands that have shown affinity towards G-quadruplex structures as well as inhibited telomerase activity [17]. The anthraquinone derivatives have received much attention due to their large <pi>-surface which can efficiently do π-π interaction with the G-tetrads. In 1997, Neidle and Hurley have first reported a 2,6-diaminoalkylamidoanthraquinone derivative, BSU-1051 as the first G-quadruplex ligand and telomerase inhibitor [17]. Subsequently, the disubstituted amido-anthraquinone derivatives are further developed at different substituent positions with varying lengths of side chains to get binding selectivity towards G-quadruplex DNA [18]. Anthraquinone moieties have been conjugated with amino acids and amino sugars to regulate their G4 DNA binding affinities [19]. Moreover, Huang et al. reported several disubstituted amido and aminoanthraquinone derivatives as human telomerase inhibitors and potential anti-cancer agents [20]. Interestingly, different chemically modified heteroarene fused anthraquinone derivatives have been explored by Shchekotikhin and co-workers as human telomeric G-quadruplex stabilizers and antiproliferative agents [21]. However, owing to their diverse medicinal significances, there is a sustained and continuing interest in search of new anthraquinone derivatives to improve their biological activities.

Naturally occurring oligopeptides like netropsin, distamycin, anthelvencin, norformycin, etc. have attracted the synthetic chemists as well as molecular biologists because of their various biological significances such as antiviral, antibacterial and anti-cancer activities [22]. Oligopyrroles such as netropsin and distamycin A are one of the most well-studied polyamides that bind in the minor groove of duplex DNA with AT-rich sequence [23]. The binding affinities of these oligopyrroles were acquired from H-bonding interactions with bases, electrostatic interactions with the phosphate backbones and van der Waals contacts with the minor groove [24]. These oligopyrroles are also well-known for the binding to the grooves of the G-quadruplex DNA, but the selectivity is comparatively poor [25]. However, we have reported earlier that when the oligopyrroles are conjugated with salen and salphen moieties, they have shown promising selectivity towards G-quadruplex DNA over duplex DNA [26]. To a similar manner, we propose that the conjugation of the oligopyrrole carboxamides with anthraquinone pharmacophore, the selectivity of the compounds towards stabilization of G-quadruplex DNA may be obtained efficiently. The rationale behind the design of the molecules presented herein is to focus on the dual recognition ability as the stacking interaction of the anthraquinone moiety to the G-tetrad and the interaction with grooves/loops with the flexible side chains. This may increase the probability of achieving selectivity of the G-quadruplex DNA over the ds-DNA.

Herein, we have synthesized new anthraquinone derivatives conjugated with different numbers of oligopyrroles to stabilize G4 structures. The compounds are designed in such a way to address some important parameters like molecular length, flexibility. The interaction of these compounds with promoter c-MYC, c-KIT1, c-KIT2 G4, and telomeric G4 DNA were studied by UV–vis spectroscopic titration. Also, the selectivity for the binding of the compounds towards G4 DNA over duplex DNA was determined from this experiment. The stabilization of G-quadruplex DNA by these compounds was also supported by fluorescence titration experiment along with CD titration, CD melting experiment, Taq polymerase stop assay. To determine the mode of interactions of these compounds with G4 DNA, ethidium bromide displacement assay, cyclic voltammetric titration, and molecular modeling studies were carried out. Further, to check the potency of these compounds in vitro condition, we have performed the MTT based cell viability assay in HeLa (human cervical cancer transformed cells), HEK 293T (human embryonic kidney transformed cells) over normal cells like NIH3T3 (primary mouse embryonic fibroblast cells) and HDFa (Human Dermal Fibroblast, adult). To ascertain the mechanistic pathway of cell death, Annexin V and PI dual staining assay were employed which further has been verified by fluorescence microscopy with AO/EB staining method. Morphological changes of the cells and nuclear condensation upon treatment with these compounds were followed by bright field microscopy and confocal microscopy respectively.

Section snippets

Results and discussion

Design and Synthesis. We have synthesized mono-, di- and tri-pyrrole compounds and have attached the varying lengths of flanking side chains to the anthraquinone moiety (Fig. 1). The side chains contain tetramethylammonium groups which are further conjugated with oligopyrrole carboxamides of different lengths to observe the role in the structure-activity relationship. The molecular length, as well as the shape of the ligands, were varied by varying the number of the pyrrole rings attached to

Conclusions

Anthraquinone derivatives are already known for the inhibition of telomerase enzyme [17] and oligopyrrole moieties are reported as groove binders for duplex DNA [23]. However, the conjugation of the oligopyrrole carboxamide with the anthraquinone chromophore is not reported so far as a target for the stabilization of G4 DNA. Hence, we have designed and synthesized disubstituted anthraquinone derivatives tagged with oligopyrrole moieties which have shown significant interactions with different

Experimental section

Materials. All the starting materials and solvents were purchased from the best known available commercial sources and used as it is without any further purification. Final compounds were thoroughly analyzed by 1H NMR, 13C NMR, mass spectra, FT-IR, and elemental analysis. 1H and 13C NMR spectra were recorded on Bruker Avance 400 and 800 (400 MHz for 1H; 100 and 200 (with cryoprobe) MHz for 13C) spectrometer. Mass and IR spectra were recorded on Micromass Q-TOF Micro TM spectrometer and FT-IR

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This work was supported by a J. C. Bose Fellowship, Department of Science and Technology (DST) to SB. SR thanks the Council of Scientific and Industrial Research (CSIR) for a senior research fellowship. We would like to acknowledge the central confocal and flow cytometry facilities, Division of Biological Sciences, IISc, for the confocal imaging and FACS.

References (44)

  • G.N. Parkinson et al.

    Crystal structure of parallel quadruplexes from human telomeric DNA

    Nature

    (2002)
    A.L. Moye et al.

    Telomeric G-quadruplexes are a substrate and site of localization for human telomerase

    Nat. Commun.

    (2015)
    M.L. Bochman et al.

    DNA secondary structures: stability and function of G-quadruplex structures

    Nat. Rev. Genet.

    (2012)
    A.T. Phan

    Human telomeric G-quadruplex: structures of DNA and RNA sequences

    FEBS J.

    (2010)
    J.-L. Mergny et al.

    Kinetics of tetramolecular quadruplexes

    Nucleic Acids Res.

    (2005)
    D. Rhodes et al.

    G-quadruplexes and their regulatory roles in biology

    Nucleic Acids Res.

    (2015)
    S. Sur et al.

    Naphthalenediimide-linked bisbenzimidazole derivatives as telomeric G-quadruplex-stabilizing ligands with improved anticancer activity

    ACS Omega

    (2017)
  • A. Ambrus et al.

    Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter, implications for G-quadruplex stabilization

    Biochemistry

    (2005)
    A.T. Phan et al.

    Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter

    J. Am. Chem. Soc.

    (2007)
    T.S. Dexheimer et al.

    Deconvoluting the structural and drug-recognition complexity of the G-quadruplex forming region upstream of the bcl-2 P1 promoter

    J. Am. Chem. Soc.

    (2006)
    S. Cogoi et al.

    G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription

    Nucleic Acids Res.

    (2006)
    P. Agrawal et al.

    Solution structure of the major G-quadruplex formed in the human VEGF promoter in K+: insights into loop interactions of the parallel G-quadruplexes

    Nucleic Acids Res.

    (2013)
    H. Chen et al.

    Exploring The formation and recognition of an important G-quadruplex in a HIF1α promoter and its transcriptional inhibition by a benzo[c]phenanthridine derivative

    J. Am. Chem. Soc.

    (2014)
  • D. Yang et al.

    Structural insights into G-quadruplexes: towards new anticancer drugs

    Future Med. Chem.

    (2010)
    A. De Rache et al.

    A flexible terpyridine derivative interacts specifically with G-quadruplexes

    Chem. Eur J.

    (2016)
  • Q. Li et al.

    G4LDB: a database for discovering and studying G-quadruplex ligands

    Nucleic Acids Res.

    (2013)
    N.H. Campbell et al.

    Molecular basis of structure-activity relationships between salphen metal complexes and human telomeric DNA quadruplexes

    J. Med. Chem.

    (2012)
    A. Paul et al.

    Chemistry and biology of DNA-binding small molecules

    Curr. Sci.

    (2012)
  • A. Adhikari et al.

    DNA targeted anthraquinone derivatives: an important anticancer agent

    Int. J. Pharm. Pharmaceut. Sci.

    (2016)
    P. Chaudhuri et al.

    Synthesis, DNA binding, and Leishmania Topoisomerase inhibition activities of a novel series of anthra[1,2-d]imidazole-6,11-dione derivatives

    J. Med. Chem.

    (2007)
  • C. Monneret

    Recent developments in the field of antitumour anthracyclines

    Eur. J. Med. Chem.

    (2001)
    D. Agudelo et al.

    Review on the binding of anticancer drug doxorubicin with DNA and tRNA: structural models and antitumor activity

    J. Photochem. Photobiol. B Biol.

    (2016)
    C.A. Frederick et al.

    Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin

    Biochemistry

    (1990)
  • E.M. Malik et al.

    Anthraquinones as pharmacological tools and drugs

    Med. Res. Rev.

    (2016)
  • M.K. Islam et al.

    Recent advances in targeting the telomeric G-quadruplex DNA sequence with small molecules as a strategy for anticancer therapies

    Future Med. Chem.

    (2016)
    B. Maji et al.

    Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA

    Chem. Commun.

    (2014)
    A.K. Jain et al.

    Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands

    Bioconjugate Chem.

    (2011)
    D.L. Ma et al.

    Recent developments in G-quadruplex probes

    Chem. Biol.

    (2015)
    A. Arola et al.

    Stabilisation of G-quadruplex DNA by small molecules

    Curr. Top. Med. Chem.

    (2008)
    S. Müller et al.

    G-quadruplex interacting small molecules and drugs: from bench toward bedside

    Expet Rev. Clin. Pharmacol.

    (2014)
    A. Ali et al.

    DNA binders in clinical trials and chemotherapy

    Bioorg. Med. Chem.

    (2014)
    S. Bhattacharya et al.

    Medical implications of benzimidazole derivatives as drugs designed for targeting DNA and DNA associated processes

    Curr. Med. Chem.

    (2008)
    Santanu Bhattacharya et al.

    DNA cleavage by intercalatable cobalt–bispicolylamine complexes activated by visible light

    Chem. Commun

    (1996)
  • V. Dhamodharan et al.

    Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives

    ACS Chem. Biol.

    (2015)
  • S. Sparapani et al.

    Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes

    J. Am. Chem. Soc.

    (2010)
    T. Agarwal et al.

    Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression

    Biochemistry

    (2010)
    A. Ali et al.

    Enhanced G-quadruplex DNA stabilization and telomerase inhibition by novel fluorescein derived salen and salphen based Ni (II) and Pd (II) complexes

    Bioconjugate Chem.

    (2016)
    G. Zagotto et al.

    Tuning G-quadruplex vs double-stranded DNA recognition in regioisomeric lysyl-peptidyl-anthraquinone conjugates

    Bioconjugate Chem.

    (2011)
    A.K. Jain et al.

    Dimeric 1,3-Phenylene-bis(piperazinyl benzimidazole)s: synthesis and structure-activity investigations on their binding with human telomeric G-quadruplex DNA and telomerase inhibition properties

    J. Med. Chem.

    (2012)
    A. Paul et al.

    Stabilization and structural alteration of the G-quadruplex DNA made from the human telomeric repeat mediated by tröger’s base based novel benzimidazole derivatives

    J. Med. Chem.

    (2012)
    B. Maji et al.

    Design and synthesis of novel benzimidazole-carbazole conjugates for the stabilization of human telomeric DNA, telomerase inhibition, and their selective action on cancer cells

    J. Med. Chem.

    (2014)
    R. Shen et al.

    Synthesis and biological evaluation of disubstituted amidoxanthones as potential telomeric G-quadruplex DNA-binding and apoptosis-inducing agents

    Bioorg. Med. Chem.

    (2016)
    J. Amato et al.

    Tailoring a lead-like compound targeting multiple G-quadruplex structures

    Eur. J. Med. Chem.

    (2019)
    P. Chaudhuri et al.

    An experimental and computational analysis on the differential role of the positional isomers of symmetric Bis-2-(pyridyl)-1H-benzimidazoles as DNA binding agents

    J. Org. Chem.

    (2007)
  • D. Sun et al.

    Inhibition of human telomerase by a G-quadruplex-interactive compound

    J. Med. Chem.

    (1997)
  • P.J. Perry et al.

    Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones

    J. Med. Chem.

    (1998)
    P.J. Perry et al.

    1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase

    J. Med. Chem.

    (1998)
    P.J. Perry et al.

    2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase

    J. Med. Chem.

    (1999)
  • Cited by (37)

    • Interface of G-quadruplex with both stabilizing and destabilizing ligands for targeting various diseases

      2022, International Journal of Biological Macromolecules
      Citation Excerpt :

      The dihydroindolizino indole derivative comprising the 4-cyanophenyl group could bind efficiently to G-quadruplex formed in the telomeric region and NHE III1, a c-MYC promoter region [115]. The anthraquinone compounds having a varying length of side chains could stabilize the G-quadruplex DNA (via stacking mode) in the promoter region of the c-MYC oncogene in comparison to duplex DNA [94]. Wu et al. have synthesized an imidazole-benzothiazole conjugate (IZTZ-1) that could favourably stabilize the G-quadruplex DNA present in the promoter region of the c-MYC gene [95].

    • A stilbene derivative as dual-channel fluorescent probe for mitochondrial G-quadruplex DNA in living cells

      2022, Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
      Citation Excerpt :

      Furthermore, the effect of 2a and 2b on the conformation of the promoter and mitochondrial G-quadruplexes was investigated in 10 mM Tris-HCl buffer containing 100 mM KCl at pH 7.0 by Circular Dichroism (CD) spectroscopy (Fig. S9). According to the characteristic peaks of CD spectra, bcl-2 [40] and HRCC [41] exhibit a mixed-type conformation, both c-kit 2 [42] and c-myc [17] are a parallel conformation, while KSS is the typical of hybrid conformation [41]. With the addition of the compounds, CD spectra of G-quadruplexes are no obvious change, suggesting that both 2a and 2b fail to induce their conformation transformation.

    • Highly selective turn-on red fluorescence probes for visualization of the G-quadruplexes DNA in living cells

      2022, Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
    View all citing articles on Scopus
    View full text